Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report issued on Wednesday. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright dropped their price target on shares of Aethlon Medical from $23.00 to $10.00 and set a buy rating for the company in a research note on Monday, March 4th.

Aethlon Medical Trading Down 1.1 %

Shares of Aethlon Medical stock opened at $1.73 on Wednesday. The company has a 50 day moving average of $1.75 and a 200-day moving average of $1.86. Aethlon Medical has a 1-year low of $1.40 and a 1-year high of $7.20. The company has a market cap of $4.53 million, a PE ratio of -0.35 and a beta of 1.89.

Aethlon Medical (NASDAQ:AEMD) last issued its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($1.37) EPS for the quarter, missing the consensus estimate of ($1.23) by ($0.14). Research analysts forecast that Aethlon Medical will post -4.98 earnings per share for the current year.

Institutional Investors Weigh In On Aethlon Medical

Large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Aethlon Medical by 112.9% during the third quarter. Vanguard Group Inc. now owns 1,053,198 shares of the medical equipment provider’s stock worth $613,000 after buying an additional 558,596 shares during the period. Renaissance Technologies LLC increased its position in shares of Aethlon Medical by 11.6% during the first quarter. Renaissance Technologies LLC now owns 270,297 shares of the medical equipment provider’s stock worth $395,000 after buying an additional 28,097 shares during the period. Citadel Advisors LLC acquired a new stake in shares of Aethlon Medical during the third quarter worth $72,000. Two Sigma Investments LP grew its holdings in Aethlon Medical by 219.3% in the first quarter. Two Sigma Investments LP now owns 127,341 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 87,458 shares during the period. Finally, Jane Street Group LLC grew its holdings in Aethlon Medical by 895.7% in the fourth quarter. Jane Street Group LLC now owns 140,245 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 126,160 shares during the period. 1.99% of the stock is currently owned by institutional investors and hedge funds.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.